Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
4.140
-0.160 (-3.72%)
At close: Oct 10, 2025, 4:00 PM EDT
4.080
-0.060 (-1.45%)
Pre-market: Oct 13, 2025, 8:00 AM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $39.11 million as of October 13, 2025. Its market cap has decreased by -44.79% in one year.
Market Cap
39.11M
Enterprise Value
62.60M
1-Year Change
-44.79%
Ranking
Category
Stock Price
$4.14
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $39.11M, a decrease of -91.04%. That is a compound annual growth rate of -28.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 39.11M | -38.31% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | 297.71M | -27.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |